REGISTER
The real-world challenges in managing ALK-positive NSCLC
Prof. Chen and Prof. Ou discussed the real-world challenges in managing ALK-positive NSCLC.

Prof. Jiaqi Chen, The Second Affiliated Hospital, China
Prof. Sai-Hong Ignatius Ou, School of Medicine, University of California, Irvine, USA


Prof. Chen and Prof. Ou discussed the real-world challenges in managing ALK-positive NSCLC, including reimbursement limitations, treatment accessibility, and the shift toward long-term chronic disease management as patient survival improves. They also shared perspectives on future directions in the field, including the potential role of first-line lorlatinib and emerging strategies such as ALK TKI-based combination therapy.

0
0
Loading